EPISODE · Feb 20, 2023 · 1H
99. Ideal Lidocaine Buffering - Melanoma Microsatellites - Aesthetic Archetypes - ILVEN - CONTEXT
from Dermasphere - The Dermatology Podcast · host Luke Johnson
Ideal buffering of lidocaine: 3:1 with bicarb [article]Melanoma microsatellites are bad [article]Aesthetic patient archetypes [article]ILVEN is heterogeneous [article]Dr. Feldman on CONTEXT [Dr. Feldman's book]Connect with us! Web: https://dermaspherepodcast.com/Twitter: @DermaspherePCInstagram: @dermaspherepodcastFacebook: https://www.facebook.com/DermaspherePodcast/Check out Luke and Michelle’s other podcast, SkinCast! https://healthcare.utah.edu/dermatology/skincast/Luke and Michelle report no significant conflicts of interest… BUT check out our friends at:Kikoxp.com (a social platform for doctors to share knowledge)https://www.levelex.com/games/top-derm(A free dermatology game to learn more dermatology!)The University of Utah Dermatology Echo: https://physicians.utah.edu/echo/dermatology-primarycare
What this episode covers
Ideal buffering of lidocaine: 3:1 with bicarb [article]Melanoma microsatellites are bad [article]Aesthetic patient archetypes [article]ILVEN is heterogeneous [article]Dr. Feldman on CONTEXT [Dr. Feldman's book]Connect with us! Web: https://dermaspherepodcast.com/Twitter: @DermaspherePCInstagram: @dermaspherepodcastFacebook: https://www.facebook.com/DermaspherePodcast/Check out Luke and Michelle’s other podcast, SkinCast! https://healthcare.utah.edu/dermatology/skincast/Luke and Michelle report no significant conflicts of interest… BUT check out our friends at:Kikoxp.com (a social platform for doctors to share knowledge)https://www.levelex.com/games/top-derm(A free dermatology game to learn more dermatology!)The University of Utah Dermatology Echo: https://physicians.utah.edu/echo/dermatology-primarycare
NOW PLAYING
99. Ideal Lidocaine Buffering - Melanoma Microsatellites - Aesthetic Archetypes - ILVEN - CONTEXT
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m